Related Experiment Video
Updated: Jun 20, 2026

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis
Hong-li Yan1, Geng Xue, Qian Mei
1Institute of Genetics, Second Military Medical University, Shanghai, China.
Abstract:
We here report that miR-17-92 cluster is a novel target for p53-mediated transcriptional repression under hypoxia. We found the expression levels of miR-17-92 cluster were reduced in hypoxia-treated cells containing wild-type p53, but were unchanged in hypoxia-treated p53-deficient cells. The repression of miR-17-92 cluster under hypoxia is independent of c-Myc. Luciferase reporter assays mapped the region responding to p53-mediated repression to a p53-binding site in the proximal region of the miR-17-92 promoter. Chromatin immunoprecipitation (ChIP), Re-ChIP and gel retardation assays revealed that the binding sites for p53- and the TATA-binding protein (TBP) overlap within the miR-17-92 promoter; these proteins were found to compete for binding. Finally, we show that pri-miR-17-92 expression correlated well with p53 status in colorectal carcinomas. Over-express miR-17-92 cluster markedly inhibits hypoxia-induced apoptosis, whereas blocked miR-17-5p and miR-20a sensitize the cells to hypoxia-induced apoptosis. These data indicated that p53-mediated repression of miR-17-92 expression likely has an important function in hypoxia-induced apoptosis, and thus further our understanding of the tumour suppressive function of p53.
Insights
The tumor suppressor p53 represses the miR-17-92 cluster under hypoxia, a key mechanism in controlling hypoxia-induced apoptosis and tumor suppression. This finding reveals a novel p53 target crucial for cellular response to low oxygen.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Hypoxia is a common feature in solid tumors, influencing tumor progression and therapeutic response.
- The p53 tumor suppressor protein plays a critical role in cellular stress responses, including those induced by hypoxia.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various cellular processes, including apoptosis and cancer.
Purpose of the Study:
- To investigate the role of the miR-17-92 cluster in hypoxia-induced apoptosis.
- To identify novel targets of p53-mediated transcriptional repression under hypoxic conditions.
- To elucidate the regulatory mechanism of miR-17-92 expression by p53 in the context of hypoxia and cancer.
Main Methods:
- Cell culture under normoxic and hypoxic conditions.
- Analysis of miR-17-92 cluster expression in wild-type p53 and p53-deficient cells.
- Luciferase reporter assays to map p53-binding sites on the miR-17-92 promoter.
- Chromatin immunoprecipitation (ChIP) and Re-ChIP assays to study protein-DNA interactions.
- Gel retardation assays to assess p53 and TATA-binding protein (TBP) competition.
- Analysis of pri-miR-17-92 expression in colorectal carcinoma tissues.
- Functional studies involving overexpression or inhibition of miR-17-92 components.
Main Results:
- Hypoxia treatment led to reduced miR-17-92 cluster expression in cells with wild-type p53, but not in p53-deficient cells.
- p53 directly represses miR-17-92 transcription via a binding site in its proximal promoter, independent of c-Myc.
- p53 and TBP binding sites on the miR-17-92 promoter overlap, indicating competition for binding.
- Pri-miR-17-92 expression levels correlated with p53 status in colorectal carcinomas.
- Overexpression of the miR-17-92 cluster inhibited hypoxia-induced apoptosis, while blocking miR-17-5p and miR-20a sensitized cells to apoptosis.
Conclusions:
- The miR-17-92 cluster is a novel target of p53-mediated transcriptional repression under hypoxia.
- p53-mediated repression of miR-17-92 plays a significant role in regulating hypoxia-induced apoptosis.
- This regulatory axis contributes to the tumor-suppressive functions of p53, offering insights into cancer biology and potential therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
